pillbase.ru

Neomycin and Polymyxin B Sulfates

Active substance: NEOMYCIN SULFATE, POLYMYXIN B SULFATE

SOLUTION · NEOMYCIN SULFATE 40 mg/mL, POLYMYXIN B SULFATE 200000 [USP'U]/mL

United StatesActive

Marketing holder: XGen Pharmaceuticals DJB, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Products containing neomycin in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

CountryProducts
RU 48
  • Аминтакс
    суппозитории вагинальные, 35000 МЕ+100000 МЕ+35000 МЕ (original in Russian, GRLS)
    ЛП-№(009121)-(РГ-RU)
    АО "Патент-Фарм"
  • Аминтакс
    суппозитории вагинальные, 35000 МЕ+100000 МЕ+35000 МЕ (original in Russian, GRLS)
    ЛП-004173
    АО "Патент-Фарм"
  • Анауран®
    капли ушные, ~, 25 мл (original in Russian, GRLS)
    ЛП-№(009376)-(РГ-RU)
    Замбон С.п.А.
  • Анауран®
    капли ушные, ~, 25 мл (original in Russian, GRLS)
    П N012942/01
    Замбон С.п.А.
  • БАКТЕРВЕКС
    мазь для наружного применения, 250 МЕ/г+5000 МЕ/г, 20 г (original in Russian, GRLS)
    ЛП-№(006952)-(РГ-RU)
    Открытое акционерное общество "Авексима"
All products in this country (48)
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c5-0577-73e0-8889-fc45c95cbc38;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
39822-1201
Registration status
Active
Dispensing
Prescription only
Route
IRRIGATION
Sources
  • product · openFDA NDC · 39822-1201 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 39822-1201 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 39822-1201 · Verified 2026-10-09 · open in source
  • ingredients.1 · openFDA NDC · 39822-1201 · Verified 2026-10-09 · open in source